BioMarin Pharmaceutical Inc, a global leader in therapies for rare genetic diseases, today opened its new offices in Dublin to provide a hub for the Company’s growing operations across EU, the Middle East and Africa (EUMEA).
The new offices in Earlsfort Terrace further strengthens BioMarin’s presence in Ireland. A €38 million expansion of BioMarin’s manufacturing facility in Cork was announced last year and is also currently in progress.
BioMarin is a global biopharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases.
The new offices were officially opened by AnTánaiste, Minister for Foreign Affairs & Trade, Simon Coveney at an event that brought together members of BioMarin’s Global Executive team including President of Global Manufacturing, Dr Robert Baffi, employees, members of the medical and life science communities, public representatives and patient representative groups including Avril Daly, Chairperson of Rare Diseases Ireland.
Speaking today, Mr Coveney said, "I welcome today’s opening and BioMarin’s recognition that Ireland is an ideal location for a business with a global reach. The presence of a highly skilled labour force supports the growth and development of their specialised and significant work in the area of the treatment of rare diseases. BioMarin has grown to a workforce of close to 500 – Irish-based staff now represent almost 20% of their employees globally, making Ireland its most significant location outside of the US."
Senior Vice President EUMEA Commercial Operations and one of BioMarin’s global leaders based in Dublin, Jim Lennertz added, "We’re benefiting from the exceptional pool of life sciences talent and expertise in Ireland, which means we can recruit the right people at a time when the Company has a number of exciting innovations in the pipeline and continues to drive strong growth in the EUMEA region. Our new offices in Dublin support our continued expansion and provide our employees with an outstanding workspace in the heart of the city."